A complication that causes drug- coated heart stents to weaken and shrink will be reviewed at a medical meeting next week, researchers said. The stent flaw, known as longitudinal compression, was added to the agenda at the Transcatheter Cardiovascular Therapeutics meeting that starts next week in San Francisco, said Gregg Stone, director of cardiovascular research at New York Presbyterian Hospital/Columbia University Medical Center and director of TCT.
